Twist Bioscience Corporation TWST Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's additional paid-in capital?
- Twist Bioscience Corporation (TWST) reported additional paid-in capital of $1.85B in Q1 2026.
- How has Twist Bioscience Corporation's additional paid-in capital changed year-over-year?
- Twist Bioscience Corporation's additional paid-in capital increased by 5.5% year-over-year, from $1.75B to $1.85B.
- What is the long-term trend for Twist Bioscience Corporation's additional paid-in capital?
- Over 5 years (2020 to 2025), Twist Bioscience Corporation's additional paid-in capital has grown at a 17.7% compound annual growth rate (CAGR), from $794.63M to $1.79B.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.